These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Reinforcement therapy using nitric oxide synthase inhibitors against endotoxin shock in dogs. Suga H; Nakagawa T; Soga Y; Deguchi Y; Suzuki T; Miyoshi N; Imamura Y; Fukuda M Surg Today; 2006; 36(9):811-7. PubMed ID: 16937286 [TBL] [Abstract][Full Text] [Related]
24. [Is use of nitric oxide (NO) synthase inhibitors justified for therapy of septic shock?]. Jonderko G; Marcisz C; Braclik M Postepy Hig Med Dosw; 2003; 57(1):67-90. PubMed ID: 12765124 [TBL] [Abstract][Full Text] [Related]
25. Effect of nitric oxide donors and nitric oxide synthase inhibitors in neonatal rat endotoxic shock. Cochran JB; Genovese F; Ogura S; Teti G; Cook JA Biochem Pharmacol; 1999 Aug; 58(4):687-91. PubMed ID: 10413307 [TBL] [Abstract][Full Text] [Related]
26. Effects of MPSS and a potent iNOS inhibitor on traumatic spinal cord injury. Yu Y; Matsuyama Y; Nakashima S; Yanase M; Kiuchi K; Ishiguro N Neuroreport; 2004 Sep; 15(13):2103-7. PubMed ID: 15486490 [TBL] [Abstract][Full Text] [Related]
27. Time-dependent aggravation or attenuation of lipopolysaccharide-induced gastric injury by nitric oxide synthase inhibition. Suliburk JW; Helmer KS; Kennison SD; Mercer DW; Robinson EK J Surg Res; 2005 Dec; 129(2):265-71. PubMed ID: 16026802 [TBL] [Abstract][Full Text] [Related]
28. Nitric oxide in sepsis-syndrome: potential treatment of septic shock by nitric oxide synthase antagonists. Ketteler M; Cetto C; Kirdorf M; Jeschke GS; Schäfer JH; Distler A Kidney Int Suppl; 1998 Feb; 64():S27-30. PubMed ID: 9475485 [TBL] [Abstract][Full Text] [Related]
29. A potent inhibitor of inducible nitric oxide synthase, ONO-1714, a cyclic amidine derivative. Naka M; Nanbu T; Kobayashi K; Kamanaka Y; Komeno M; Yanase R; Fukutomi T; Fujimura S; Seo HG; Fujiwara N; Ohuchida S; Suzuki K; Kondo K; Taniguchi N Biochem Biophys Res Commun; 2000 Apr; 270(2):663-7. PubMed ID: 10753680 [TBL] [Abstract][Full Text] [Related]
30. Effect of nitric oxide synthase (NOS) inhibition on macro- and microcirculation in a model of rat endotoxic shock. Pullamsetti SS; Maring D; Ghofrani HA; Mayer K; Weissmann N; Rosengarten B; Lehner M; Schudt C; Boer R; Grimminger F; Seeger W; Schermuly RT Thromb Haemost; 2006 Apr; 95(4):720-7. PubMed ID: 16601845 [TBL] [Abstract][Full Text] [Related]
31. Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study. Avontuur JA; Tutein Nolthenius RP; van Bodegom JW; Bruining HA Crit Care Med; 1998 Apr; 26(4):660-7. PubMed ID: 9559602 [TBL] [Abstract][Full Text] [Related]
32. Effects of nitric oxide synthase inhibitors on systemic hypotension, cytokines and inducible nitric oxide synthase expression and lung injury following endotoxin administration in rats. Wang D; Wei J; Hsu K; Jau J; Lieu MW; Chao TJ; Chen HI J Biomed Sci; 1999 Jan; 6(1):28-35. PubMed ID: 9933740 [TBL] [Abstract][Full Text] [Related]
33. Protective effect of a novel and selective inhibitor of inducible nitric oxide synthase on experimental crescentic glomerulonephritis in WKY rats. Ogawa D; Shikata K; Matsuda M; Okada S; Usui H; Wada J; Taniguchi N; Makino H Nephrol Dial Transplant; 2002 Dec; 17(12):2117-21. PubMed ID: 12454221 [TBL] [Abstract][Full Text] [Related]
34. Glabridin, an isoflavan from licorice root, inhibits inducible nitric-oxide synthase expression and improves survival of mice in experimental model of septic shock. Kang JS; Yoon YD; Cho IJ; Han MH; Lee CW; Park SK; Kim HM J Pharmacol Exp Ther; 2005 Mar; 312(3):1187-94. PubMed ID: 15537821 [TBL] [Abstract][Full Text] [Related]
35. Effects of an inducible nitric oxide synthase inhibitor on experimentally induced rat pulpitis. Kawanishi HN; Kawashima N; Suzuki N; Suda H; Takagi M Eur J Oral Sci; 2004 Aug; 112(4):332-7. PubMed ID: 15279652 [TBL] [Abstract][Full Text] [Related]
36. Bicyclic amidine inhibitors of nitric oxide synthase: discovery of perhydro-iminopyrindine and perhydro-iminoquinoline as potent, orally active inhibitors of inducible nitric oxide synthase. Guthikonda RN; Shah SK; Pacholok SG; Humes JL; Mumford RA; Grant SK; Chabin RM; Green BG; Tsou N; Ball R; Fletcher DS; Luell S; Euan MacIntyre D; Maccoss M Bioorg Med Chem Lett; 2005 Apr; 15(8):1997-2001. PubMed ID: 15808455 [TBL] [Abstract][Full Text] [Related]
37. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction. Kato Y; Miura Y; Yamamoto N; Ozaki N; Oiso Y Diabetologia; 2003 Sep; 46(9):1228-33. PubMed ID: 12898012 [TBL] [Abstract][Full Text] [Related]
39. Remnant liver injury after hepatectomy with the pringle maneuver and its inhibition by an iNOS inhibitor (ONO-1714) in a pig model. Kukita K; Katsuramaki T; Kikuchi H; Meguro M; Nagayama M; Kimura H; Isobe M; Hirata K J Surg Res; 2005 May; 125(1):78-87. PubMed ID: 15836854 [TBL] [Abstract][Full Text] [Related]
40. 1400W, a potent selective inducible NOS inhibitor, improves histopathological outcome following traumatic brain injury in rats. Jafarian-Tehrani M; Louin G; Royo NC; Besson VC; Bohme GA; Plotkine M; Marchand-Verrecchia C Nitric Oxide; 2005 Mar; 12(2):61-9. PubMed ID: 15740979 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]